US Patent 11835527 Deglycosylation methods for electrophoresis of glycosylated proteins
Patent 11835527 was granted and assigned to Regeneron Pharmaceuticals on December, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Infobox (+49 properties)
Article (+215 characters)
US Patent 11835527 Deglycosylation methods for electrophoresis of glycosylated proteins
Article
Patent abstract
The disclosure relates to methods of analyzing a post-translationally modified protein of interest using electrophoresis, the methods comprising deglycosylating the protein of interest after labeling.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Gabriel Carreau0
Hunter Chen0
Shao-Chun Wang0
Timothy Riehlman0
Yiming Zhao0
Ying Wang0
Date of Patent
December 5, 2023
0Patent Application Number
171531500
Date Filed
January 20, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11835527 Deglycosylation methods for electrophoresis of glycosylated proteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
